Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639171 · ClinicalTrials.gov registry record
Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 3
- Enrollment target
NCT00639171 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 3 participants.
The verdict
NCT00639171 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Magnetic Resonance Spectroscopy (MRS) is a novel imaging technique for noninvasive probing of biochemical properties of tissue. While MRS does not generate images of tumor per se it allows biochemical spectroscopic data to be obtained in vivo from user defined region-of-interest. In this manner, biochemical information elucidated by MRS can be interpreted in relation to detailed anatomy and images of metabolite distribution can be created. The aim of MRS is to identify presence and concentration of metabolites characteristic for normal and abnormal (tumor) cellular activities hence allow differential normal tissue from pathological tissue, as well as allow differentiating malignant from benign tumors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-11 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00639171
The ClinicalTrials.gov registry entry for NCT00639171 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00639171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00639171 about?
NCT00639171 is a clinical study titled "Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant". Magnetic Resonance Spectroscopy (MRS) is a novel imaging technique for noninvasive probing of biochemical properties of tissue. While MRS does not generate images of tumor per se it allows biochemical spectroscopic data to be obtained in vivo from user defined region-of-interest. In this manner, bio...
What is the current status of trial NCT00639171?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2005-11. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT00639171?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.